Tekla Healthcare Investors (HQH)
Company Info
ISIN | US87911J1034 |
---|---|
CUSIP | 87911J103 |
Sector | Financial Services |
Industry | Asset Management |
Highlights
Market Cap | $938.08M |
---|---|
EPS (TTM) | $1.31 |
PE Ratio | 14.15 |
Total Revenue (TTM) | $72.73M |
Gross Profit (TTM) | $62.17M |
EBITDA (TTM) | $122.74M |
Year Range | $12.71 - $19.19 |
Short Ratio | 1.16 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: HQH vs. RQI, HQH vs. XLV, HQH vs. SPY, HQH vs. VOO, HQH vs. NOBL, HQH vs. JEPI, HQH vs. USA, HQH vs. ARCC, HQH vs. DX, HQH vs. VUG
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Tekla Healthcare Investors, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Tekla Healthcare Investors had a return of 22.14% year-to-date (YTD) and 27.47% in the last 12 months. Over the past 10 years, Tekla Healthcare Investors had an annualized return of 5.03%, while the S&P 500 had an annualized return of 10.55%, indicating that Tekla Healthcare Investors did not perform as well as the benchmark.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | 22.14% | 13.39% |
1 month | 4.29% | 4.02% |
6 months | 15.09% | 5.56% |
1 year | 27.47% | 21.51% |
5 years (annualized) | 9.45% | 12.69% |
10 years (annualized) | 5.03% | 10.55% |
Monthly Returns
The table below presents the monthly returns of HQH, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | 3.38% | 0.97% | 0.24% | -4.21% | 6.15% | 5.43% | 6.36% | 5.27% | 22.14% | ||||
2023 | 5.67% | -3.29% | -1.84% | -1.36% | -1.47% | 1.73% | 0.06% | -0.59% | -6.10% | -6.05% | 4.64% | 11.13% | 1.22% |
2022 | -5.01% | -9.13% | 3.80% | -2.79% | -0.86% | -4.50% | 3.37% | -1.77% | -7.10% | 8.51% | 4.43% | -6.15% | -17.27% |
2021 | 0.04% | 6.81% | -2.20% | 1.84% | 0.67% | 4.93% | 0.89% | 5.00% | -4.41% | 2.15% | -5.42% | -1.82% | 7.99% |
2020 | -3.88% | -3.28% | -6.12% | 14.43% | 6.15% | 0.52% | -1.22% | 3.37% | -3.10% | -4.03% | 12.68% | 9.45% | 24.81% |
2019 | 17.44% | -0.73% | 0.10% | -3.80% | -2.37% | 6.53% | -1.79% | -2.74% | -2.08% | 5.83% | 8.18% | 1.41% | 26.77% |
2018 | 4.21% | -2.77% | -3.80% | -3.07% | 4.12% | 1.13% | 3.77% | 6.09% | -0.17% | -11.02% | 3.25% | -13.49% | -13.10% |
2017 | 7.24% | 9.63% | -1.39% | 5.16% | -3.43% | 4.98% | 2.51% | 1.29% | -1.14% | -6.66% | -2.05% | 0.04% | 16.04% |
2016 | -19.66% | -1.83% | 5.31% | 3.92% | 5.64% | -9.26% | 11.28% | -4.53% | -2.66% | -11.84% | 11.19% | -7.53% | -22.45% |
2015 | 7.27% | 6.03% | -0.97% | -3.50% | 9.14% | -1.33% | 3.10% | -7.81% | -16.39% | 19.31% | -3.60% | -1.87% | 4.99% |
2014 | 0.33% | 13.20% | -9.66% | -2.35% | 0.07% | 1.03% | 3.91% | 5.39% | 0.32% | 6.97% | 9.41% | -3.46% | 25.72% |
2013 | 10.85% | 1.60% | 4.44% | 9.91% | 3.88% | 2.63% | 7.09% | -5.24% | 4.72% | 2.25% | 8.35% | 3.53% | 68.02% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current risk-adjusted rank of HQH is 85, placing it in the top 15% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Tekla Healthcare Investors (HQH) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Tekla Healthcare Investors granted a 11.07% dividend yield in the last twelve months. The annual payout for that period amounted to $2.04 per share.
Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dividend | $2.04 | $1.60 | $1.71 | $2.04 | $1.90 | $1.72 | $1.93 | $1.98 | $2.07 | $3.55 | $2.22 | $1.73 |
Dividend yield | 11.07% | 9.66% | 9.50% | 8.59% | 7.96% | 8.22% | 10.73% | 8.76% | 9.78% | 11.96% | 7.05% | 6.41% |
Monthly Dividends
The table displays the monthly dividend distributions for Tekla Healthcare Investors. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024 | $0.00 | $0.48 | $0.00 | $0.00 | $0.59 | $0.00 | $0.00 | $0.59 | $0.00 | $1.66 | |||
2023 | $0.00 | $0.42 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.38 | $0.00 | $1.60 |
2022 | $0.00 | $0.48 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.40 | $0.00 | $0.00 | $0.39 | $0.00 | $1.71 |
2021 | $0.00 | $0.51 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.52 | $0.00 | $0.00 | $0.51 | $0.00 | $2.04 |
2020 | $0.00 | $0.47 | $0.00 | $0.00 | $0.41 | $0.00 | $0.00 | $0.49 | $0.00 | $0.00 | $0.48 | $0.05 | $1.90 |
2019 | $0.00 | $0.41 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.45 | $0.00 | $0.00 | $0.41 | $0.00 | $1.72 |
2018 | $0.00 | $0.48 | $0.00 | $0.00 | $0.47 | $0.00 | $0.00 | $0.47 | $0.00 | $0.00 | $0.51 | $0.00 | $1.93 |
2017 | $0.00 | $0.45 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.51 | $0.00 | $0.00 | $0.52 | $0.00 | $1.98 |
2016 | $0.00 | $0.61 | $0.00 | $0.00 | $0.49 | $0.00 | $0.00 | $0.47 | $0.00 | $0.00 | $0.50 | $0.00 | $2.07 |
2015 | $0.00 | $0.63 | $0.00 | $0.00 | $0.68 | $0.00 | $0.00 | $0.71 | $0.00 | $0.00 | $0.59 | $0.94 | $3.55 |
2014 | $0.00 | $0.53 | $0.00 | $0.00 | $0.54 | $0.00 | $0.00 | $0.56 | $0.00 | $0.00 | $0.59 | $0.00 | $2.22 |
2013 | $0.37 | $0.00 | $0.00 | $0.42 | $0.00 | $0.00 | $0.44 | $0.00 | $0.00 | $0.50 | $0.00 | $1.73 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Tekla Healthcare Investors. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Tekla Healthcare Investors was 56.17%, occurring on Dec 8, 1994. Recovery took 1273 trading sessions.
The current Tekla Healthcare Investors drawdown is 9.50%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-56.17% | Jan 10, 1992 | 738 | Dec 8, 1994 | 1273 | Dec 23, 1999 | 2011 |
-55.13% | May 6, 1987 | 123 | Oct 28, 1987 | 490 | Oct 5, 1989 | 613 |
-53.33% | Feb 18, 2000 | 662 | Oct 9, 2002 | 1094 | Feb 14, 2007 | 1756 |
-45.31% | Aug 18, 2008 | 140 | Mar 9, 2009 | 469 | Jan 14, 2011 | 609 |
-41.84% | Jul 20, 2015 | 144 | Feb 11, 2016 | 1225 | Dec 23, 2020 | 1369 |
Volatility
Volatility Chart
The current Tekla Healthcare Investors volatility is 5.81%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Tekla Healthcare Investors compared to its peers in the Asset Management industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for HQH in comparison to other companies of the Asset Management industry. Currently, HQH has a PE value of 14.1. This PE ratio falls in the average range for the industry.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for HQH in comparison to other companies of the Asset Management industry. Currently, HQH has a PEG value of 0.0. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Tekla Healthcare Investors.
Loading data...
Income Statement
TTM | |
---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |